zunveyl
Generic: benzgalantamine
zunveyl: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Alpha Cognition Inc. (ACOG) | Phase 4 |
FDA Decisions
Approval(ACOG)
Frequently asked questions
Who is developing zunveyl?
zunveyl is being developed by Alpha Cognition Inc..
What is zunveyl's latest FDA decision?
The most recent tracked FDA decision for zunveyl is Approval, dated July 26, 2024.
Get deeper analysis on zunveyl
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis